Book chapter
195 - Disorders of Lipid Metabolism
Goldman-Cecil Medicine, pp.1355-1365.e2
Elsevier Inc, 26th Edition
2020
DOI: 10.1016/B978-0-323-53266-2.00195-8
Abstract
Disorders of lipid metabolism are an increasingly common consequence of modern industrial lifestyles. The most common clinical manifestation of lipid disorders is atherosclerotic cardiovascular disease (ASCVD) resulting from elevated levels of apo B-100 lipoproteins. Despite tremendous advances in acute treatment, and improvements in smoking cessation and risk factor control, ASCVD remains the leading cause of death in almost every developed country in the world. Statins are the first-line lipid-modifying therapy for ASCVD risk reduction based on extensive clinical trial data that they reduce fatal and nonfatal ASCVD events and overall mortality.
Details
- Title: Subtitle
- 195 - Disorders of Lipid Metabolism
- Creators
- Jennifer G. Robinson
- Resource Type
- Book chapter
- Publication Details
- Goldman-Cecil Medicine, pp.1355-1365.e2
- Edition
- 26th Edition
- Publisher
- Elsevier Inc
- DOI
- 10.1016/B978-0-323-53266-2.00195-8
- Language
- English
- Date published
- 2020
- Academic Unit
- Epidemiology; Fraternal Order of Eagles Diabetes Research Center
- Record Identifier
- 9984363562302771
Metrics
19 Record Views